TickerFactsScreenerDevelopers

Dianthus Therapeutics, Inc. /DE/ (DNTH) — Operating Income

Annual figures by fiscal year, from SEC filings.

2016: -$9.27M2017: -$35.73M2018: -$59.96M2019: -$82.97M2020: -$78.70M2021: -$74.69M2022: -$29.70M2023: -$48.17M2024: -$101.86M2025: -$177.93M-$177.93M
2016Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$177.93M-74.7%
2024-$101.86M-111.5%
2023-$48.17M-62.2%
2022-$29.70M+60.2%
2021-$74.69M+5.1%
2020-$78.70M+5.1%
2019-$82.97M-38.4%
2018-$59.96M-67.8%
2017-$35.73M-285.5%
2016-$9.27M—